These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9576978)

  • 1. Estrogen and cancellous bone loss in the fowl.
    Wilson S; Thorp BH
    Calcif Tissue Int; 1998 Jun; 62(6):506-11. PubMed ID: 9576978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The less potent estrogenic effect of tamoxifen on bone in ovariectomized rats with established osteopenia.
    Li X; Takahashi M; Kushida K; Inoue T
    Calcif Tissue Int; 1998 Jun; 62(6):502-5. PubMed ID: 9576977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption.
    Turner RT; Evans GL; Wakley GK
    J Bone Miner Res; 1993 Mar; 8(3):359-66. PubMed ID: 8456590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.
    Turner RT; Evans GL; Sluka JP; Adrian MD; Bryant HU; Turner CH; Sato M
    Endocrinology; 1998 Sep; 139(9):3712-20. PubMed ID: 9724022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.
    Iwamoto J; Yeh JK; Takeda T
    J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tamoxifen on bone mineral density and blood lipids in ovariectomized rats.
    Czerny B; Pawlik A; Juzyszyn Z; Myśliwiec Z
    Pol J Pharmacol; 2003; 55(6):1137-42. PubMed ID: 14730112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat.
    Erben RG; Bante U; Birner H; Stangassinger M
    Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shortened tamoxifen induction scheme to induce CreER recombinase without side effects on the male mouse skeleton.
    Jardí F; Laurent MR; Dubois V; Khalil R; Deboel L; Schollaert D; Van Den Bosch L; Decallonne B; Carmeliet G; Claessens F; Vanderschueren D
    Mol Cell Endocrinol; 2017 Sep; 452():57-63. PubMed ID: 28504114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen stimulates cancellous bone formation in long bones of female mice.
    Perry MJ; Gujra S; Whitworth T; Tobias JH
    Endocrinology; 2005 Mar; 146(3):1060-5. PubMed ID: 15576459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation.
    Oxlund H; Andreassen TT
    Bone; 2004 Apr; 34(4):609-18. PubMed ID: 15050891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.
    Turner RT; Wakley GK; Hannon KS; Bell NH
    Endocrinology; 1988 Mar; 122(3):1146-50. PubMed ID: 3342747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats.
    Gallagher A; Chambers TJ; Tobias JH
    Endocrinology; 1993 Dec; 133(6):2787-91. PubMed ID: 8243306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tamoxifen and fluoride on bone mineral density, biomechanical properties and blood lipids in ovariectomized rats.
    Czerny B; Pawlik A; Juzyszyn Z; Myśliwiec Z
    Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):162-5. PubMed ID: 15504151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone.
    Willson TM; Norris JD; Wagner BL; Asplin I; Baer P; Brown HR; Jones SA; Henke B; Sauls H; Wolfe S; Morris DC; McDonnell DP
    Endocrinology; 1997 Sep; 138(9):3901-11. PubMed ID: 9275080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in female rats.
    Gallagher AC; Chambers TJ; Tobias JH
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E407-12. PubMed ID: 8638685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
    Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
    Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone.
    Sibonga JD; Bell NH; Turner RT
    J Bone Miner Res; 1998 May; 13(5):863-70. PubMed ID: 9610751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.